Reported prevalence of von Willebrand disease worldwide in relation to income classification

The diagnosis of von Willebrand disease (VWD) is complex and challenging, especially when diagnostic resources are limited. This results in a lack of consistency in identifying and reporting the number of people with VWD and variations in the VWD prevalence worldwide.

[1]  C. Hermans,et al.  The 2021 von Willebrand disease guidelines: Clarity and controversy , 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  P. Kouides,et al.  Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States , 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  E. Mikkelsen,et al.  Incidence of von Willebrand disease in Denmark, 1995‐2016: A cohort study , 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

[4]  R. Mustafa,et al.  ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. , 2021, Blood advances.

[5]  Jeffrey S. Stonebraker,et al.  The World Federation of Hemophilia Annual Global Survey 1999‐2018 , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  Jeffrey S. Stonebraker,et al.  Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males , 2019, Annals of Internal Medicine.

[7]  C. Rothschild,et al.  Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A. , 2014, Blood.

[8]  Jeffrey S. Stonebraker,et al.  A study of variations in the reported haemophilia B prevalence around the world , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  Emmanuel Favaloro1,et al.  Diagnosis and Management of von Willebrand Disease in Australia , 2011, Seminars in thrombosis and hemostasis.

[10]  E. Favaloro,et al.  von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding Disorder , 2011, Seminars in thrombosis and hemostasis.

[11]  C. Ruan,et al.  Diagnosis and Management of von Willebrand Disease in China , 2011, Seminars in thrombosis and hemostasis.

[12]  Jeffrey S. Stonebraker,et al.  A study of variations in the reported haemophilia A prevalence around the world , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  P. Mannucci,et al.  Impact, Diagnosis and Treatment of von Willebrand Disease , 2000, Thrombosis and Haemostasis.

[14]  X. Capdevila,et al.  Preoperative screening for von Willebrand disease type 1: low yield and limited ability to predict bleeding. , 1999, The Journal of laboratory and clinical medicine.

[15]  J. Shults,et al.  Prevalence of von Willebrand disease in children: a multiethnic study. , 1993, The Journal of pediatrics.

[16]  F Rodeghiero,et al.  Epidemiological investigation of the prevalence of von Willebrand's disease. , 1987, Blood.

[17]  R. Liesner,et al.  The Diagnosis and Management of Factor VIII and IX Inhibitors : A Guideline from the United Kingdom Haemophilia Centre Doctors Organisation ( UKHCDO ) , 2007 .

[18]  Mark Brooker,et al.  The world federation of hemophilia , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[19]  P. Dyke.  The National Blood Authority. , 1997, Health estate journal : journal of the Institute of Hospital Engineering.